C-S Yee

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients

C-S Yee, Vernon T. Farewell, David Isenberg et al. · Lara D. Veeken · 2011 · 212 citations · Full text

Medicine, Biostatistics, Clinical Epidemiology +15

EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis

C-S Yee · Annals of the Rheumatic Diseases · 2004 · 98 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus

C-S Yee · British journal of rheumatology · 2003 · 90 citations · Full text

Life Sciences, Immunology, Autoimmunity +15

Effects of rituximab on resistant SLE disease including lung involvement

V. Toescu, C-S Yee, A. Prabu et al. · Lupus · 2008 · 65 citations

Life Sciences, Immunology, Pharmacotherapy +17

BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000

C-S Yee, David Isenberg, Athiveer Prabu et al. · Annals of the Rheumatic Diseases · 2007 · 60 citations · Full text

Medicine, Internal Medicine, Health Assessment +13